"wHAT'S BUGGING the GUT in OCD?" A REVIEW of the GUT MICROBIOME in OBSESSIVE-COMPULSIVE DISORDER

Depression and Anxiety

Volumn 33, Issue 3, 2016, Pages 171-178

  Turna, Jasmine ^a   Grosman Kaplan, Keren ^a   Anglin, Rebecca ^a   Van Ameringen, Michael ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

anxiety; gut microbiota; gut brain axis; inflammation; obsessive compulsive disorder; OCD

Indexed keywords

CORTICOTROPIN; CYTOKINE; GASTROINTESTINAL HORMONE; HYDROCORTISONE; INTERLEUKIN 6; NEUROTRANSMITTER; SEROTONIN 1B RECEPTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ACTINOBACTERIA; ANXIETY DISORDER; BACTEROIDETES; CYTOKINE PRODUCTION; FECES MICROFLORA; FIRMICUTES; FUSOBACTERIA; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREACTIVITY; INFLAMMATION; INNATE IMMUNITY; INTESTINE FLORA; MAJOR DEPRESSION; MENTAL DISEASE; MOOD DISORDER; NERVE CELL; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PROTEOBACTERIA; REVIEW; ANIMAL; IMMUNOLOGY; MICROBIOLOGY;

ANIMALS; GASTROINTESTINAL MICROBIOME; HUMANS; OBSESSIVE-COMPULSIVE DISORDER;

EID: 84959269746     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22454     Document Type: Review

References (90)

1. Kugler BB, Lewin AB, Phares V, et al., Quality of life in obsessive-compulsive disorder: the role of mediating variables. Psychiatry Res 2013; 206: 43-49.
2. Foster J, Neufeld K,. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 2013; 36: 305-312.
3. Collins SM, Surette M, Bercik P,. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 2012; 10: 735-742.
4. Cryan JF, Dinan TG,. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012; 13: 701-712.
5. Morgan XC, Tickle TL, Sokol H, et al., Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012; 13: R79.
6. Gill SR, Pop M, DeBoy RT, et al., Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-1359.
7. Rees JC., Obsessive-compulsive disorder and gut microbiota dysregulation. Med Hypotheses 2014; 82: 163-166.
8. Faith JJ, Guruge JL, Charbonneau M, et al., The long-term stability of the human gut microbiota. Science 2013; 341 (6141): 1237439. doi: 10.1126/science.1237439
9. Eckburg PB, Bik EM, Bernstein CN, et al., Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638.
10. Parracho HM, Bingham MO, Gibson GR, McCartney AL,. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 2005; 54: 987-991.
11. Nadal I, Donant E, Ribes-Koninckx C, et al., Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol 2007; 56: 1669-1674.
12. Brown CT, Davis-Richardson AG, Giongo A, et al., Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 2011; 6: e25792.
13. Turnbaugh PJ, Ley RE, Mahowald MA, et al., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1131.
14. Heijtz RD, Wang S, Anuar F, et al., Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 2011; 108: 3047-3052.
15. Clarke G, Grenham S, Scully P, et al., The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 2012; 18: 666-673.
16. Neufeld K, Kang N, Bienenstock J, Foster JA,. Effects of intestinal microbiota on anxiety-like behavior. Commun Integr Biol 2011; 4: 492-494.
17. Neufeld K, Kang N, Bienenstock J, Foster JA,. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011; 23: 255-e119.
18. Desbonnet L, Clarke G, Traplin A, et al., Gut microbiota depletion from early adolescence in mice: implications for brain and behaviour. Brain Behav Immun 2015; 48: 165-173.
19. Bercik P, Park AJ, Sinclair D, et al., The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 2011; 23: 1132-1139.
20. Bravo JA, Forsythe P, Chew MV, et al., Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011; 108: 16050-16055.
21. Desbonnet L, Garrett L, Clarke G, et al., Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010; 170: 1179-1188.
22. O'Mahony SM, Marchesi JR, Scully P, et al., Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 2009; 65: 263-267.
23. Bangsgaard Bendtsen KM, Krych L, Sorensen DB, et al., Gut microbiota composition is correlated to grid floor induced stress and behaviour in the BALB/c mouse. PLoS One 2012; 7: e46231.
24. Bailey MT, Dowd SE, Galley JD, et al., Exposure to social stressor alters the structure of the intestinal microbiota: implications for stressor induced immunomodulation. Brain Behav Immun 2011; 25: 397-407.
25. Beck D, Settles M, Foster JA,. OTUbase: an R infrastructure package for operational taxonomic unit data. Bioinformatics 2011; 27: 1700-1701.
26. Naseribafrouei A, Hestad K, Avershina E, et al., Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil 2014; 26: 1155-1162.
27. Jiang H, Ling, Z, Zhang, et al., Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 2015; 48: 18-194.
28. Crumeyrolle-Arias M, Jaglin M, Bruneau A, et al., Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats. Psychoneuroendocrinology 2014; 42: 207-217.
29. Lyte M., Probiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probiotics. Bioessays 2011; 33: 574-581.
30. Sudo N, Chida Y, Aiba Y, et al., Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004; 558: 263-275.
31. Maes M, Twisk FN, Kubera M, et al., Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome. J Affect Disord 2013; 136: 909-917.
32. Maes, M, Ringel K, Kubera M, et al., In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation. J Affect Disord 2013; 150: 223-230.
33. Qin L, Wu X, Block ML, et al., Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007; 55: 453-462.
34. Severance E, Gressitt L, Stallings C, et al., Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr Res 2013; 148: 130-137.
35. Ait-Belgnaoui A., Durand H, Cartier C, et al., Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 2012; 37: 1885-1895.
36. Ait-Belgnaoui A, Colom A, Braniste V, et al., Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterol Motil 2014; 26: 510-520.
37. Savignac HM, Kiely B, Dinan TG, Cryan JF,. Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol Motil 2014; 26: 1615-1627.
38. Thayer JF, Sternberg EM,. Neural concomitants of immunity-focus on the vagus nerve. Neuroimage 2009; 47: 908-910.
39. Round JL, Mazmanian SK,. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9: 313-323.
40. Talham GL, Jiang HQ, Bos NA, Cebra JJ,. Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect Immun 1999; 67: 1992-2000.
41. Umesaki Y, Okada Y, Matsumoto S, et al., Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC class II molecules and fucosylasialo GM1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse. Microbiol Immunol 1995; 39: 555-562.
42. Umesaki Y, Setoyama H, Matsumoto S, et al., Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect Immun 1999; 67: 3504-3511.
43. Kamada N, Seo S, Chen GY, Nunez G,. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013; 13: 321-335.
44. Kamada N, &, Nunez G,. Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 2014; 146: 1477-1488.
45. Ritchie ML, Romanuk TN,. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 2012; 7: e34938.
46. Dinan TG, Cryan JF,. Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol Motil 2013; 25: 713-719.
47. Dantzer R, O'Connor JC, Freund GG, et al., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46-56.
48. Laske C, Zank M, Klein R, et al., Autoantibody reactivity in serum of patients with major depression, schizophrenia and healthy controls. Psychiatry Res 2008; 158: 83-86.
49. Eisenberger NI, Berkman ET, Inagaki TK, et al., Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry 2010; 68: 748-754.
50. Haroon E, Raison CL, &, Miller AH,. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012; 37: 137-162.
51. Benros ME, Nielsen PR, Nordentoft M, et al., Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry 2011; 168: 1303-1310.
52. McNally L, Bhagwagar Z, Hannestad J,. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr 2008; 13: 501-510.
53. Harrison NA, Brydon L, Walker C, et al., Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 2009; 66: 407-414.
54. Raison CL, &, Miller AH,. Is depression an inflammatory disorder? Curr Psychiatry Rep 2011; 13: 467-475.
55. Musselman DL, Lawson D, Gumnick J, et al., Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001; 344 (13): 961-966.
56. Raison CL, Woolwine BJ, Demetrashvili MF, et al., Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. Aliment Pharmacol Ther 2007; 25: 1163-1174.
57. Dowlati Y, Herrmann N, Swardfager W, et al., A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446-457.
58. Najjar S, Pearlman DM, Alper K, et al., Neuroinflammation and psychiatric illness. J Neuroinflammation 2013; 10: 10-43.
59. Setiawan E, Wilson AA, Mizrahi R, et al., Role of translocator protein density, a marker of neuroinflammation, ion the brain during major depressive episodes. JAMA Psychiatry 2015; 72: 268-275.
60. Dantzer R, Wollman E, Vitkovic L, Yirmiya R,. Cytokines and depression: Fortuitous or causative association? Mol Psychiatry 1999; 4: 328-332.
61. Vallieres L, &Rivest S,. Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. Endocrinology 1999; 140: 3890-3903.
62. Chrousos GP., The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351-1362.
63. McCann SM, Lyson K, Karanth S, et al., Mechanism of action of cytokines to induce the pattern of pituitary hormone secretion in infection. Ann N Y Acad Sci 1995; 771: 386-395.
64. Schrocksnadel K, Wirleitner B, Winkler C, Fuchs D,. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 2006; 364: 82-90.
65. Heyes MP, Saito K, Crowley JS, et al., Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992; 115 (5): 1249-1273.
66. Mellor AL, Munn DH,. Tryptophan catabolism and T-cell tolerance: Immunosuppression by starvation? Immunol Today 1999; 20: 469-473.
67. Schwarcz R, Whetsell WO, Jr., Mangano RM,. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 1983; 219: 316-318.
68. Stone TW, Behan WM,. Interleukin-1beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: protection by an adenosine A2A receptor antagonist. J Neurosci Res 2007; 85: 1077-1085.
69. Kantak PA, Bobrow DN, Nyby JG,. Obsessive-compulsive-like behaviors in house mice are attenuated by a probiotic (Lactobacillus rhamnosus GG). Behav Pharmacol 2014; 25 (1): 71-79.
70. Shanahan NA, Velez LP, Masten VL, Dulawa SC,. Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice. Biol Psychiatry 2011; 70: 1039-1048.
71. Messaoudi M, Violle N, Bisson J, et al., Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2011; 2 (4): 256-261.
72. Swedo SE, Seidlitz J, Kovacevic M, et al., Clinical presentation of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections in research and community settings. J Child Adolesc Psychopharmacol 2015; 25: 26-30.
73. Kumar A, Williams, M, Chugani,. Evaluation of basal ganglia and thalamic inflammation in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection and Tourette syndrome: positron emission tomographic (PET) study using 11C-[R]-PK11195. J Child Neurol 2015; 30 (6): 749-756.
74. Swedo SE., Streptoccocal infection, Tourette syndrome, and OCD: is there a connection? Pandas: horse or zebra? Neurology 2010; 74: 1397-1398.
75. Morer A, Lazaro L, Sabater L, et al., Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndrome. J Psychiatr Res 2008; 42: 64-68.
76. Dietrich DE, Zhang Y, Bode L, et al., Brain potential amplitude varies as a function of Borna disease virus-specific immune complexes in obsessive-compulsive disorder. Mol Psychiatry 2005; 10: 519-520.
77. Miman O, Mutlu EA, Ozcan O, et al., Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder? Psychiatry Res 2010; 177: 263-265.
78. Teixeira AL, Rodrigues DH, Marques AH, et al., Searching for the immune basis of obsessive-compulsive disorder. Neuroimmunomodulation 2014; 21: 152-158.
79. Rao NP, Venkatasubramanian G, Ravi V, et al., Plasma cytokine abnormalities in drug-naïve, comorbidity-free obsessive-compulsive disorder. Psychiatry Res 2015; 229 (3): 949-952.
80. Gray SM, Bloch MH,. Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Curr Psychiatry Rep 2012; 14: 220-228.
81. Fontenelle LF, Barbosa IG, Luna JV, et al., A cytokine study of adult patients with obsessive-compulsive disorder. Compr Psychiatry 2012; 53: 797-804.
82. Denys D, de Geus F, van Megen HJ, Westenberg HG,. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry 2004; 65: 1040-1048.
83. Gustafsson PE, Gustafsson PA, Ivarsson T, Nelson N,. Diurnal cortisol levels and cortisol response in youths with obsessive-compulsive disorder. Neuropsychobiology 2008; 57: 14-21.
84. Kluge M, Schüssler P, Künzel HE, et al., Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder. J Psychiatr Res 2007; 41: 928-933.
85. Catapano F, Monteleone P, Fuschino A, et al., Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder. Psychiatry Res 1992; 44: 217-225.
86. Monteleone P, Catapano F, Tortorella A, Maj M,. Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect. Neuropsychobiology 1997; 36: 8-12.
87. Frodl T, O'Keane V,. How does the brain deal with cumulative stress? A review with focus on developmental stress, HPA axis function and hippocampal structure in humans. Neurobiol Dis 2013; 52: 24-37.
88. Rosso G, Albert U, Asinari GF, et al., Stressful life events and obsessive-compulsive disorder: clinical features and symptom dimensions. Psychiatry Res 2012; 197: 259-264.
89. Real E, Labad J, Alonso P, et al., Stressful life events at onset of obsessive-compulsive disorder are associated with a distinct clinical pattern. Depress Anxiety 2011; 28 (5): 367-376.
90. Desbonnet L, Garrett L, Clarke G, et al., The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatric Res 2008; 43: 164-174.